CEO Schwarz sold his last company to Roche and they're involved int he current trial so far from impossible! I just hope management is realistic about that and won't keep trying to go it alone so they can collect major salaries and bonuses for putting investors on the welfare rolls.
The joint trial with Herceptin IS promising and not a blind study like the one that bombed, though why it works in combo and was a placebo alone after "successful" Ph 1-2 trials has never been explained.
The GALE 400-series is also due to share results by EOY, harry's right, there are real catalysts here.
And all of a sudden after the tanking of the PPS their IR person started responding to investor emails and signing "warmly." Well I don't think "warmly" is being reciprocated, they owe us, keep their feet to the fire everyone:
ir@galenabiopharma.com
BTW what happened to Apollo and MyFale?
Pier seems to be just another duped well-meaning investor, waiting for the company to prove itself -- regaining faith is a long haul BUT as IMHO @these prices it's prob a good time to jump in if you're not already collecting welfare.
